Restructuring and other impairment charges (Tables)

12 Months Ended

Dec. 31, 2015

Restructuring and Related Activities [Abstract]

Summary Of Current Cost Estimates By Major Type Of Cost Table

The following table provides a summary of the Company’s current aggregate cost estimates by major type of expense associated with the 2014 Manufacturing Footprint Realignment Plan:

Type of expense	Total estimated amount expected to be incurred
Termination benefits	$11 million to $13 million
Facility closure and other exit costs (1)	$2 million to $3 million
Accelerated depreciation charges	$10 million to $11 million
Other (2)	$14 million to $17 million
	$37 million to $44 million

(1) Includes costs to transfer product lines among facilities and outplacement and employee relocation costs.

(2) Consists of other costs directly related to the plan, including project management, legal and regulatory costs.

The following table provides a summary of the Company's current cost estimates by major type of expense associated with the Plan:

Type of expense	Total estimated amount expected to be incurred
Employee termination benefits	$14 million to $18 million
Facility closure and other exit costs (1)	$2 million to $3 million
Accelerated depreciation charges	$10 million to $13 million
Other (2)	$8 million to $10 million
	$34 million to $44 million

(1)    Includes costs to transfer product lines among facilities and outplacement and employee relocation costs.

(2)     Consists of other costs directly related to the Plan, including project management, legal and other regulatory costs.

Restructuring and Other Impairment Charges

The restructuring and other impairment charges recognized for the years ended December 31, 2015, 2014 and 2013 consisted of the following:

	2015
(dollars in thousands)	Termination Benefits			Facility Closure Costs		Contract Termination Costs			Other Exit Costs		Total
2015 Restructuring programs	$	5,009		$	231	$	1,000		$	64	$	6,304
2014 Manufacturing footprint realignment plan	$	1,007		$	241	$	389		$	48	$	1,685
Other restructuring programs - prior years(1)	$	(194	)	$	2	$	(13	)	$	35	$	(170	)
Total restructuring charges	$	5,822		$	474	$	1,376		$	147	$	7,819

(1) Other restructuring programs - prior years includes the 2014 European restructuring plan, the Other 2014 restructuring programs, the 2013 Restructuring programs and the LMA restructuring program.

	2014
(dollars in thousands)	Termination Benefits			Facility Closure Costs			Contract Termination Costs			Other Exit Costs		Total
2014 Manufacturing footprint realignment plan	$	9,200		$	—		$	—		$	60	$	9,260
2014 European restructuring plan	7,237			1			345			225		7,808
Other 2014 restructuring programs	552			—			2,754			244		3,550
LMA restructuring program	(29		)	(112		)	(3,188		)	—		$	(3,329	)
2013 Restructuring programs	562			—			249			22		833
2012 Restructuring program	(619		)	354			—			—		(265		)
2011 Restructuring plan	—			12			—			—		12
Total restructuring charges	$	16,903		$	255		$	160		$	551	$	17,869

	2013
(dollars in thousands)	Termination Benefits		Facility Closure Costs		Contract Termination Costs		Other Exit Costs		Total
LMA restructuring program	$	3,282	$	788	$	7,906	$	176	12,152
2013 Restructuring programs	4,787		—		3,326		2,117		10,230
2012 Restructuring program	2,993		935		296		5		4,229
2011 Restructuring plan	—		42		728		—		770
2007 Arrow integration program	—		230		—		—		230
	$	11,062	$	1,995	$	12,256	$	2,298	$	27,611
Impairment charges	—		—		—		10,841		10,841
Total restructuring and other impairment charges	$	11,062	$	1,995	$	12,256	$	13,139	38,452

Termination benefits include employee retention, severance and benefit payments for terminated employees. Facility closure costs include general operating costs incurred subsequent to production shutdown as well as equipment relocation and other associated costs. Contract termination costs include costs associated with terminating existing leases and distributor agreements. Other costs include legal, outplacement and employee relocation costs and other employee-related costs.

Restructuring charges by reportable operating segment for the years ended December 31, 2015, 2014, and 2013 are set forth in the following table:

	2015		2014		2013
	(Dollars in thousands)
Vascular North America	$	3,742	$	8,057	$	5,348
Anesthesia North America	384		1,379		2,959
Surgical North America	397		—		6,525
EMEA	4		6,375		16,122
Asia	313		1,305		603
OEM	61		—		588
All other	2,918		753		6,307
Total restructuring charges	$	7,819	$	17,869	$	38,452